R. Hunter

Southern Research Institute — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index2.5kcitations56works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(8), Viral gastroenteritis research and epidemiology(6), Vector-Borne Animal Diseases(6), HIV/AIDS drug development and treatment(5), Animal Virus Infections Studies(5)

Publications56 total

Small Molecule RBI2 Disrupts Ribosome Biogenesis through Pre-rRNA Depletion
Cancers·2023· 2 citedOpen Access
Inhibitors of HIV-1 Nef-Mediated Activation of the Myeloid Src-Family Kinase Hck Block HIV-1 Replication in Macrophages and Disrupt MHC-I Downregulation
ACS Infectious Diseases·2022· 13 citedOpen Access
Investigation of Bacterial Infections Among Patients Treated With Umbilical Cord Blood–Derived Products Marketed as Stem Cell Therapies
JAMA Network Open·2021· 11 citedOpen Access
NCMP-09. POSTMORTEM STUDY OF ORGAN SPECIFIC TOXICITY IN GLIOBLASTOMA PATIENTS TREATED WITH A COMBINATION OF TEMOZOLOMIDE, BEVACIZUMAB AND IRINOTECAN
Neuro-Oncology·2020Open Access
GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia
Neuropsychopharmacology·2020· 29 citedOpen Access
Discovery of novel inhibitors of ribosome biogenesis by innovative high throughput screening strategies
Biochemical Journal·2019· 25 citedOpen Access
Pyrazolopyrimidinones, a novel class of copper-dependent bactericidal antibiotics against multi-drug resistant <i>S. aureus</i>
Metallomics·2019· 11 citedOpen Access
Identification of Immune and Viral Correlates of Norovirus Protective Immunity through Comparative Study of Intra-Cluster Norovirus Strains
PLoS Pathogens·2013· 106 citedOpen Access
The third described case of transfusion‐transmitted <i>Babesia duncani</i>
Transfusion·2011· 81 cited
Transmission of<i>Trypanosoma cruzi</i>by Heart Transplantation
Clinical Infectious Diseases·2009· 114 cited
Discovery of (<i>R</i>)-6-Cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a Potent and Orally Available Hepatitis C Virus Polymerase Inhibitor
Journal of Medicinal Chemistry·2009· 118 citedOpen Access
Transmission of Trypanosoma cruzi Infection by Organ Transplantation, Los Angeles County, 2006
International Journal of Infectious Diseases·2008Open Access
Discovery of 5-[[4-[(2,3-Dimethyl-2<i>H</i>-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor
Journal of Medicinal Chemistry·2008· 342 citedOpen Access
Aza-stilbenes as potent and selective c-RAF inhibitors
Bioorganic & Medicinal Chemistry Letters·2006· 19 citedOpen Access
Chagas Disease After Organ Transplantation - Los Angeles, California, 2006
PsycEXTRA Dataset·2006· 107 cited
Discovery and Evaluation of 2-Anilino-5-aryloxazoles as a Novel Class of VEGFR2 Kinase Inhibitors
Journal of Medicinal Chemistry·2005· 135 citedOpen Access
Discovery and in vitro Evaluation of Potent TrkA Kinase Inhibitors: Oxindole and Aza‐Oxindoles.
ChemInform·2004· 1 cited
Discovery and in vitro evaluation of potent TrkA kinase inhibitors: oxindole and aza-oxindoles
Bioorganic & Medicinal Chemistry Letters·2004· 132 citedOpen Access
Retraction
Science·2002· 8 cited
ChemInform Abstract: Synthesis of 5‐Substituted 7‐Azaoxindoles via Palladium‐Catalyzed Reactions.
ChemInform·2001
page 1 of 3Next →

Frequent Co-authors

G.W. Horner(14), Karen Lackey(10), Philip A. Harris(9), Lee F. Kuyper(7), James M. Veal(6), Stephen V. Frye(5), Edgar R. Wood(5), Victoria B. Knick(4), H. Neal Bramson(4), Stephen T. Davis(4), Robert T. Gampe(4), Anne M. Hassell(4), William D. Holmes(4), Brett Lovejoy(4), Michael J. Luzzio(4), Warren J. Rocque(4), Robert Griffin(4), David A. Leiby(4), Mui Cheung(3), Scott H. Dickerson(3)